What the man in the street thinks about human enhancement
By Michael Cook,
BioEdge
| 05. 07. 2016
[citing CGS consultant Pete Shanks]
Untitled Document
What does the American public think about human germline enhancement? A survey of 17 polls taken over the 30 years published in the New England Journal of Medicine suggests that Americans support gene therapy for patients with serious diseases, but they oppose it in embryos or germ cells. The authors conclude: “Of course, public opinion could change over time as discussions of these issues continue to evolve and as more is learned about the implications and safety of gene-editing technologies.”
However, Pete Shanks, at the Center for Genetics and Society, in California, reaches a different conclusion from much the same information. The latest polls show that more than 80% of people surveyed thought that babies should not be genetically modified for increased intelligence or sporting ability. “These are, or should be, devastating numbers to anyone who thinks that the public supports human heritable genetic modification,” he concludes.
Image via Pixabay
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...